Possibia

457938

Last Update Posted: 2018-10-16

Recruiting has ended

All Genders

accepted

14 Years-70 Years

4 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Novel Therapies for Metabolic Complications of Lipodystrophies

Lipodystrophies represent a therapeutic challenge with regards to the management of the diabetes, insulin resistance, hypertriglyceridemia and fatty liver which frequently present in conjunction with significant adipose tissue loss. The purpose of the study and it's four subprojects is to examine the safety and efficacy of various novel interventions designed to improve or resolve the fatty liver, hypertriglyceridemia, and insulin resistance or diabetes that is seen in these patients.

We propose novel therapeutic approaches for the management of metabolic complications in patients with lipodystrophies. The four interventions to be tested are:

Hypothesis 1: An extremely low fat diet.

Eligibility

Relevant conditions:

Insulin Resistance

Hypertriglyceridemia

Diabetes

Hepatic Steatosis

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov